Aylin Lindemann

672 total citations
3 papers, 85 citations indexed

About

Aylin Lindemann is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Aylin Lindemann has authored 3 papers receiving a total of 85 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Infectious Diseases, 1 paper in Neurology and 1 paper in Epidemiology. Recurrent topics in Aylin Lindemann's work include Protease and Inhibitor Mechanisms (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Cell Adhesion Molecules Research (1 paper). Aylin Lindemann is often cited by papers focused on Protease and Inhibitor Mechanisms (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Cell Adhesion Molecules Research (1 paper). Aylin Lindemann collaborates with scholars based in Germany, Italy and Canada. Aylin Lindemann's co-authors include Markus F. Neurath, Moritz Leppkes, Martin Herrmann, Georg Schett, Eva Martini, Jay V. Patankar, Christian Maueröder, Christoph Becker, Stefan Wirtz and Nora Naumann‐Bartsch and has published in prestigious journals such as Frontiers in Immunology, Cells and Frontiers in Medicine.

In The Last Decade

Aylin Lindemann

3 papers receiving 85 citations

Peers

Aylin Lindemann
Comparison fields: 5 of 26
  • Immunology 65
  • Molecular Biology 36
  • Infectious Diseases 21
  • Pulmonary and Respiratory Medicine 14
  • Genetics 11
Replace Anna Roppelt with:
Anna Roppelt Russia
Ana Maria Van Den Rym Spain
Florianne Hafkamp Netherlands
Luc Roberts Canada
Gregor Dombrowsky Germany
Christopher Chang United States
Lion F. K. Uhl United Kingdom
Jiazhen Dong China
Sonoko Sakata Japan
Ryohtaroh Matsumoto Japan
Anna Roppelt Russia View profile →
Citations per field, relative to Aylin Lindemann
Aylin Lindemann · 1×
Citations per year, relative to Aylin Lindemann
Aylin Lindemann · 1×

Countries citing papers authored by Aylin Lindemann

Since Specialization
Citations

This map shows the geographic impact of Aylin Lindemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aylin Lindemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aylin Lindemann more than expected).

Fields of papers citing papers by Aylin Lindemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aylin Lindemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aylin Lindemann. The network helps show where Aylin Lindemann may publish in the future.

Co-authorship network of co-authors of Aylin Lindemann

This figure shows the co-authorship network connecting the top 25 collaborators of Aylin Lindemann. A scholar is included among the top collaborators of Aylin Lindemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aylin Lindemann. Aylin Lindemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026